<?xml version="1.0" encoding="UTF-8"?>
<questel-patent-document lang="en" date-produced="20180805" produced-by="Questel" schema-version="3.23" file="US06179882B2.xml">
  <bibliographic-data lang="en">
    <publication-reference publ-desc="Granted patent as second publication">
      <document-id>
        <country>US</country>
        <doc-number>06179882</doc-number>
        <kind>B2</kind>
        <date>20010130</date>
      </document-id>
      <document-id data-format="questel">
        <doc-number>US6179882</doc-number>
      </document-id>
    </publication-reference>
    <original-publication-kind>B2</original-publication-kind>
    <application-reference family-id="9490473" extended-family-id="457841">
      <document-id>
        <country>US</country>
        <doc-number>09155211</doc-number>
        <kind>A</kind>
        <date>19990616</date>
      </document-id>
      <document-id data-format="questel">
        <doc-number>1997US-09155211</doc-number>
      </document-id>
      <document-id data-format="questel_Uid">
        <doc-number>469516</doc-number>
      </document-id>
    </application-reference>
    <language-of-filing>en</language-of-filing>
    <language-of-publication>en</language-of-publication>
    <priority-claims>
      <priority-claim kind="national" sequence="1">
        <country>FR</country>
        <doc-number>9603629</doc-number>
        <kind>A</kind>
        <date>19960322</date>
        <priority-active-indicator>Y</priority-active-indicator>
      </priority-claim>
      <priority-claim data-format="questel" sequence="1">
        <doc-number>1996FR-0003629</doc-number>
      </priority-claim>
      <priority-claim kind="international" sequence="2">
        <country>WO</country>
        <doc-number>FR9700506</doc-number>
        <kind>A</kind>
        <date>19970321</date>
        <priority-linkage-type>W</priority-linkage-type>
        <priority-active-indicator>N</priority-active-indicator>
      </priority-claim>
      <priority-claim data-format="questel" sequence="2">
        <doc-number>1997WO-FR00506</doc-number>
      </priority-claim>
    </priority-claims>
    <dates-of-public-availability>
      <publication-of-grant-date>
        <date>20010130</date>
      </publication-of-grant-date>
    </dates-of-public-availability>
    <classifications-ipcr>
      <classification-ipcr sequence="1">
        <text>A61K   8/00        20060101AFI20060310RMJP</text>
        <ipc-version-indicator>
          <date>20060101</date>
        </ipc-version-indicator>
        <classification-level>A</classification-level>
        <section>A</section>
        <class>61</class>
        <subclass>K</subclass>
        <main-group>8</main-group>
        <subgroup>00</subgroup>
        <symbol-position>F</symbol-position>
        <classification-value>I</classification-value>
        <generating-office>
          <country>JP</country>
        </generating-office>
        <classification-status>R</classification-status>
        <classification-data-source>M</classification-data-source>
        <action-date>
          <date>20060310</date>
        </action-date>
      </classification-ipcr>
      <classification-ipcr sequence="2">
        <text>A45D  19/00        20060101A I20051110RMEP</text>
        <ipc-version-indicator>
          <date>20060101</date>
        </ipc-version-indicator>
        <classification-level>A</classification-level>
        <section>A</section>
        <class>45</class>
        <subclass>D</subclass>
        <main-group>19</main-group>
        <subgroup>00</subgroup>
        <classification-value>I</classification-value>
        <generating-office>
          <country>EP</country>
        </generating-office>
        <classification-status>R</classification-status>
        <classification-data-source>M</classification-data-source>
        <action-date>
          <date>20051110</date>
        </action-date>
      </classification-ipcr>
      <classification-ipcr sequence="3">
        <text>A61K   8/20        20060101ALI20060310RMJP</text>
        <ipc-version-indicator>
          <date>20060101</date>
        </ipc-version-indicator>
        <classification-level>A</classification-level>
        <section>A</section>
        <class>61</class>
        <subclass>K</subclass>
        <main-group>8</main-group>
        <subgroup>20</subgroup>
        <symbol-position>L</symbol-position>
        <classification-value>I</classification-value>
        <generating-office>
          <country>JP</country>
        </generating-office>
        <classification-status>R</classification-status>
        <classification-data-source>M</classification-data-source>
        <action-date>
          <date>20060310</date>
        </action-date>
      </classification-ipcr>
      <classification-ipcr sequence="4">
        <text>A61K   8/22        20060101ALI20060310RMJP</text>
        <ipc-version-indicator>
          <date>20060101</date>
        </ipc-version-indicator>
        <classification-level>A</classification-level>
        <section>A</section>
        <class>61</class>
        <subclass>K</subclass>
        <main-group>8</main-group>
        <subgroup>22</subgroup>
        <symbol-position>L</symbol-position>
        <classification-value>I</classification-value>
        <generating-office>
          <country>JP</country>
        </generating-office>
        <classification-status>R</classification-status>
        <classification-data-source>M</classification-data-source>
        <action-date>
          <date>20060310</date>
        </action-date>
      </classification-ipcr>
      <classification-ipcr sequence="5">
        <text>A61K   8/34        20060101ALI20060310RMJP</text>
        <ipc-version-indicator>
          <date>20060101</date>
        </ipc-version-indicator>
        <classification-level>A</classification-level>
        <section>A</section>
        <class>61</class>
        <subclass>K</subclass>
        <main-group>8</main-group>
        <subgroup>34</subgroup>
        <symbol-position>L</symbol-position>
        <classification-value>I</classification-value>
        <generating-office>
          <country>JP</country>
        </generating-office>
        <classification-status>R</classification-status>
        <classification-data-source>M</classification-data-source>
        <action-date>
          <date>20060310</date>
        </action-date>
      </classification-ipcr>
      <classification-ipcr sequence="6">
        <text>A61K   8/41        20060101ALI20060310RMJP</text>
        <ipc-version-indicator>
          <date>20060101</date>
        </ipc-version-indicator>
        <classification-level>A</classification-level>
        <section>A</section>
        <class>61</class>
        <subclass>K</subclass>
        <main-group>8</main-group>
        <subgroup>41</subgroup>
        <symbol-position>L</symbol-position>
        <classification-value>I</classification-value>
        <generating-office>
          <country>JP</country>
        </generating-office>
        <classification-status>R</classification-status>
        <classification-data-source>M</classification-data-source>
        <action-date>
          <date>20060310</date>
        </action-date>
      </classification-ipcr>
      <classification-ipcr sequence="7">
        <text>A61K   8/49        20060101ALI20060310RMJP</text>
        <ipc-version-indicator>
          <date>20060101</date>
        </ipc-version-indicator>
        <classification-level>A</classification-level>
        <section>A</section>
        <class>61</class>
        <subclass>K</subclass>
        <main-group>8</main-group>
        <subgroup>49</subgroup>
        <symbol-position>L</symbol-position>
        <classification-value>I</classification-value>
        <generating-office>
          <country>JP</country>
        </generating-office>
        <classification-status>R</classification-status>
        <classification-data-source>M</classification-data-source>
        <action-date>
          <date>20060310</date>
        </action-date>
      </classification-ipcr>
      <classification-ipcr sequence="8">
        <text>A61Q   5/10        20060101ALI20060310RMJP</text>
        <ipc-version-indicator>
          <date>20060101</date>
        </ipc-version-indicator>
        <classification-level>A</classification-level>
        <section>A</section>
        <class>61</class>
        <subclass>Q</subclass>
        <main-group>5</main-group>
        <subgroup>10</subgroup>
        <symbol-position>L</symbol-position>
        <classification-value>I</classification-value>
        <generating-office>
          <country>JP</country>
        </generating-office>
        <classification-status>R</classification-status>
        <classification-data-source>M</classification-data-source>
        <action-date>
          <date>20060310</date>
        </action-date>
      </classification-ipcr>
    </classifications-ipcr>
    <classification-national>
      <country>US</country>
      <main-classification>
        <text>008409000</text>
        <class>008</class>
        <subclass>409000</subclass>
      </main-classification>
      <further-classification sequence="1">
        <text>008423000</text>
        <class>008</class>
        <subclass>423000</subclass>
      </further-classification>
      <further-classification sequence="2">
        <text>008567000</text>
        <class>008</class>
        <subclass>567000</subclass>
      </further-classification>
      <further-classification sequence="3">
        <text>008573000</text>
        <class>008</class>
        <subclass>573000</subclass>
      </further-classification>
    </classification-national>
    <patent-classifications>
      <patent-classification sequence="1">
        <classification-scheme office="EP" scheme="CPC">
          <date>20130101</date>
        </classification-scheme>
        <classification-symbol>A61Q-005/10</classification-symbol>
        <section>A</section>
        <class>61</class>
        <subclass>Q</subclass>
        <main-group>5</main-group>
        <subgroup>10</subgroup>
        <symbol-position>F</symbol-position>
        <classification-value>I</classification-value>
        <classification-status>B</classification-status>
        <classification-data-source>H</classification-data-source>
        <action-date>
          <date>20130101</date>
        </action-date>
      </patent-classification>
      <patent-classification sequence="2">
        <classification-scheme office="EP" scheme="CPC">
          <date>20130101</date>
        </classification-scheme>
        <classification-symbol>A61K-008/4953</classification-symbol>
        <section>A</section>
        <class>61</class>
        <subclass>K</subclass>
        <main-group>8</main-group>
        <subgroup>4953</subgroup>
        <symbol-position>L</symbol-position>
        <classification-value>I</classification-value>
        <classification-status>B</classification-status>
        <classification-data-source>H</classification-data-source>
        <action-date>
          <date>20130101</date>
        </action-date>
      </patent-classification>
    </patent-classifications>
    <number-of-claims>7</number-of-claims>
    <exemplary-claim>1</exemplary-claim>
    <figures>
      <number-of-drawing-sheets>0</number-of-drawing-sheets>
      <number-of-figures>0</number-of-figures>
      <image-key data-format="questel">US6179882</image-key>
    </figures>
    <invention-title format="original" lang="en" id="title_en">Keratin fibre dye composition containing pyrazolopyrimidinoxo compounds, use thereof as dye couplers, and dyeing methods</invention-title>
    <references-cited>
      <citation srep-phase="applicant">
        <patcit num="1">
          <text>KARL-HEINZ MENZEL, et al</text>
          <document-id>
            <country>US</country>
            <doc-number>3061432</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>US3061432</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="2">
          <text>BARR CHARLES R, et al</text>
          <document-id>
            <country>US</country>
            <doc-number>3227554</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>US3227554</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="3">
          <text>YOUNG DAVID V</text>
          <document-id>
            <country>US</country>
            <doc-number>3419391</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>US3419391</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="4">
          <text>BAILEY J, et al</text>
          <document-id>
            <country>US</country>
            <doc-number>3725067</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>US3725067</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="5">
          <text>BERTH P</text>
          <document-id>
            <country>US</country>
            <doc-number>3820948</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>US3820948</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="6">
          <text>ARAI ATSUAKI, et al</text>
          <document-id>
            <country>US</country>
            <doc-number>3926631</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>US3926631</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="7">
          <text>GREENWALD RICHARD B</text>
          <document-id>
            <country>US</country>
            <doc-number>4128425</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>US4128425</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="8">
          <text>COTTE JEAN-MARIE, et al</text>
          <document-id>
            <country>US</country>
            <doc-number>4293543</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>US4293543</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="9">
          <text>SATO TADAHISA, et al</text>
          <document-id>
            <country>US</country>
            <doc-number>4500630</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>US4500630</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="10">
          <text>SUZUKI MAKOTO, et al</text>
          <document-id>
            <country>US</country>
            <doc-number>5256526</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>US5256526</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="11">
          <text>TANG PING W, et al</text>
          <document-id>
            <country>US</country>
            <doc-number>5441863</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>US5441863</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="12">
          <text>KIM CHANG K, et al</text>
          <document-id>
            <country>US</country>
            <doc-number>5457210</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>US5457210</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="13">
          <text>EICHENBERGER THOMAS, et al</text>
          <document-id>
            <country>US</country>
            <doc-number>5785720</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>US5785720</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="14">
          <text>THERACHEMIE CHEM THERAPEUT</text>
          <document-id>
            <country>DE</country>
            <doc-number>2160317</doc-number>
            <kind>A1</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>DE2160317</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="15">
          <text>SCHTSCHUTSCHINSKIJ</text>
          <document-id>
            <country>DE</country>
            <doc-number>2359999</doc-number>
            <kind>A1</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>DE2359999</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="16">
          <text>RUETGERSWERKE AG</text>
          <document-id>
            <country>DE</country>
            <doc-number>3731395</doc-number>
            <kind>A1</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>DE3731395</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="17">
          <text>WELLA AG</text>
          <document-id>
            <country>DE</country>
            <doc-number>3843892</doc-number>
            <kind>A1</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>DE3843892</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="18">
          <text>HENKEL KGAA</text>
          <document-id>
            <country>DE</country>
            <doc-number>4009097</doc-number>
            <kind>A1</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>DE4009097</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="19">
          <text>WELLA AG</text>
          <document-id>
            <country>DE</country>
            <doc-number>4133957</doc-number>
            <kind>A1</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>DE4133957</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="20">
          <text>HENKEL KGAA</text>
          <document-id>
            <country>EP</country>
            <doc-number>0030680</doc-number>
            <kind>A1</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>EP--30680</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="21">
          <text>FUJI PHOTO FILM CO LTD</text>
          <document-id>
            <country>EP</country>
            <doc-number>0119860</doc-number>
            <kind>A2</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>EP-119860</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="22">
          <text>EASTMAN KODAK CO</text>
          <document-id>
            <country>EP</country>
            <doc-number>0285274</doc-number>
            <kind>A1</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>EP-285274</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="23">
          <text>KONISHIROKU PHOTO IND</text>
          <document-id>
            <country>EP</country>
            <doc-number>0304001</doc-number>
            <kind>A2</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>EP-304001</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="24">
          <text>RUETGERSWERKE AG</text>
          <document-id>
            <country>EP</country>
            <doc-number>0309652</doc-number>
            <kind>A2</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>EP-309652</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="25">
          <text>BAYER AG</text>
          <document-id>
            <country>EP</country>
            <doc-number>0320764</doc-number>
            <kind>A2</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>EP-320764</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="26">
          <text>FUJI PHOTO FILM CO LTD</text>
          <document-id>
            <country>EP</country>
            <doc-number>0456226</doc-number>
            <kind>A1</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>EP-456226</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="27">
          <text>ASS GESTION ECOLE FR PAPETERIE, et al</text>
          <document-id>
            <country>EP</country>
            <doc-number>0488909</doc-number>
            <kind>A1</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>EP-488909</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="28">
          <text>FUJI PHOTO FILM CO LTD</text>
          <document-id>
            <country>EP</country>
            <doc-number>0488248</doc-number>
            <kind>A1</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>EP-488248</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="29">
          <text>FUJI PHOTO FILM CO LTD</text>
          <document-id>
            <country>EP</country>
            <doc-number>0518238</doc-number>
            <kind>A1</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>EP-518238</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="30">
          <text>UNILEVER PLC, et al</text>
          <document-id>
            <country>EP</country>
            <doc-number>0547864</doc-number>
            <kind>A1</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>EP-547864</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="31">
          <text>FUJI PHOTO FILM CO LTD</text>
          <document-id>
            <country>EP</country>
            <doc-number>0557851</doc-number>
            <kind>A1</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>EP-557851</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="32">
          <text>FUJI PHOTO FILM CO LTD</text>
          <document-id>
            <country>EP</country>
            <doc-number>0578248</doc-number>
            <kind>A2</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>EP-578248</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="33">
          <text>CIBA GEIGY AG</text>
          <document-id>
            <country>EP</country>
            <doc-number>0591103</doc-number>
            <kind>A1</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>EP-591103</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="34">
          <document-id>
            <country>FR</country>
            <doc-number>1564999</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>FR1564999</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="35">
          <text>EASTMAN KODAK CO</text>
          <document-id>
            <country>FR</country>
            <doc-number>2075583</doc-number>
            <kind>A5</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>FR2075583</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="36">
          <text>ELF AQUITAINE</text>
          <document-id>
            <country>FR</country>
            <doc-number>2466492</doc-number>
            <kind>A1</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>FR2466492</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="37">
          <text>ROSSMANN GERARD</text>
          <document-id>
            <country>FR</country>
            <doc-number>2486913</doc-number>
            <kind>A1</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>FR2486913</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="38">
          <text>SCHWARZKOPF VERWALTUNG G M B H</text>
          <document-id>
            <country>GB</country>
            <doc-number>1026978</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>GB1026978</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="39">
          <text>SCHWARZKOPF VERWALTUNG G M B H, et al</text>
          <document-id>
            <country>GB</country>
            <doc-number>1153196</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>GB1153196</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="40">
          <text>KODAK LTD</text>
          <document-id>
            <country>GB</country>
            <doc-number>1458377</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>GB1458377</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="41">
          <text>EASTMAN KODAK CO</text>
          <document-id>
            <country>JP</country>
            <doc-number>S5842045</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>JP58042045</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="42">
          <text>FUJI PHOTO FILM CO LTD</text>
          <document-id>
            <country>JP</country>
            <doc-number>S5999437</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>JP59099437</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="43">
          <text>FUJI PHOTO FILM CO LTD</text>
          <document-id>
            <country>JP</country>
            <doc-number>S59162548</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>JP59162548</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="44">
          <text>FUJI PHOTO FILM CO LTD</text>
          <document-id>
            <country>JP</country>
            <doc-number>S59171956</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>JP59171956</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="45">
          <text>FUJI PHOTO FILM CO LTD</text>
          <document-id>
            <country>JP</country>
            <doc-number>S6033552</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>JP60033552</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="46">
          <text>FUJI PHOTO FILM CO LTD</text>
          <document-id>
            <country>JP</country>
            <doc-number>S6043659</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>JP60043659</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="47">
          <text>FUJI PHOTO FILM CO LTD</text>
          <document-id>
            <country>JP</country>
            <doc-number>S60172982</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>JP60172982</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="48">
          <text>FUJI PHOTO FILM CO LTD</text>
          <document-id>
            <country>JP</country>
            <doc-number>S60190779</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>JP60190779</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="49">
          <text>KONISHIROKU PHOTO IND</text>
          <document-id>
            <country>JP</country>
            <doc-number>S62279337</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>JP62279337</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="50">
          <text>NEC CORP</text>
          <document-id>
            <country>JP</country>
            <doc-number>S63169571</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>JP63169571</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="51">
          <text>KAO CORP</text>
          <document-id>
            <country>JP</country>
            <doc-number>S6236011</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>JP62036011</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="52">
          <text>KONISHIROKU PHOTO IND</text>
          <document-id>
            <country>JP</country>
            <doc-number>H0736159</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>JP07036159</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="53">
          <text>KONISHIROKU PHOTO IND</text>
          <document-id>
            <country>JP</country>
            <doc-number>H0784348</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>JP07084348</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="54">
          <text>KONISHIROKU PHOTO IND</text>
          <document-id>
            <country>JP</country>
            <doc-number>H0792632</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>JP07092632</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="55">
          <text>PFIZER LTD, et al</text>
          <document-id>
            <country>WO</country>
            <doc-number>9204349</doc-number>
            <kind>A1</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>WO9204349</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="56">
          <text>HENKEL KGAA</text>
          <document-id>
            <country>WO</country>
            <doc-number>9204883</doc-number>
            <kind>A1</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>WO9204883</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="57">
          <text>SCHERING PLOUGH HEALTHCARE, et al</text>
          <document-id>
            <country>WO</country>
            <doc-number>9404130</doc-number>
            <kind>A1</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>WO9404130</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="58">
          <text>TAISHO PHARMA CO LTD, et al</text>
          <document-id>
            <country>WO</country>
            <doc-number>9408959</doc-number>
            <kind>A1</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>WO9408959</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="59">
          <text>WELLA AG, et al</text>
          <document-id>
            <country>WO</country>
            <doc-number>9408969</doc-number>
            <kind>A1</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>WO9408969</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <patcit num="60">
          <text>WELLA AG, et al</text>
          <document-id>
            <country>WO</country>
            <doc-number>9408970</doc-number>
            <kind>A1</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>WO9408970</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="applicant">
        <nplcit num="1">
          <text>R. Stollé, "Ueber die Ueberführung der secundären Säurehydrazide in Derivate des Furodiazols, Pyyrodiazols und Thiodiazols", Chemischen Gesellschaft, pp. 797-798, 1899.</text>
        </nplcit>
      </citation>
      <citation srep-phase="applicant">
        <nplcit num="2">
          <text>Hans Beyer et al., "{umlaut over (U)}ber die Pyrazolbildung aus alpha-Chlor-actessigester und Thiocarbohydazid", Chemische Bericht, pp. 2550-2555, 1956.</text>
        </nplcit>
      </citation>
      <citation srep-phase="applicant">
        <nplcit num="3">
          <text>H. Wilde et al., Synthese von 4H-Pyrazolo[1,5-a]benzimidazolen, Journal Für Praktische Chemie, pp. 829-836, 1984.</text>
        </nplcit>
      </citation>
      <citation srep-phase="applicant">
        <nplcit num="4">
          <text>Lidia Wyzgowska et al., "O Reakcjach Trikarboetoksymetanu VIII", Acta Poloniae Pharmaceutica, pp. 83-88, 1982.</text>
        </nplcit>
      </citation>
      <citation srep-phase="applicant">
        <nplcit num="5">
          <text>E. Hannig et al., "Zur Kenntnis des 4-aminierten Phenylbutazons", Die Pharmazie, p. 231, 1980.</text>
        </nplcit>
      </citation>
      <citation srep-phase="applicant">
        <nplcit num="6">
          <text>Giuliana Cardillo et al., "Su due constituenti minori della Kamala", Gazetta Chimica Italiana, pp. 725-734, 1965.</text>
        </nplcit>
      </citation>
      <citation srep-phase="applicant">
        <nplcit num="7">
          <text>Thomas Kauffmann et al., Synthese von Amidrazonon aus Nitrilen und Natriumhydrazid, pp. 3436-3443, 1964.</text>
        </nplcit>
      </citation>
      <citation srep-phase="applicant">
        <nplcit num="8">
          <text>von Helmut Dorn et al., "Synthese und Methylierung von 1H-Pyrazolo[3,4-b]pyrazinen, einer neuen Klasse von Purin-Antagonisten", Annalen der Chemie, pp. 118-123, 1968.</text>
        </nplcit>
      </citation>
      <citation srep-phase="applicant">
        <nplcit num="9">
          <text>von Helmut Dorn et al., "{umlaut over (U)}ber die elektrophile Substitution von 3(5)-Amino-pyrazol", Annalen der Chemie, pp. 141-146, 1967.</text>
        </nplcit>
      </citation>
      <citation srep-phase="applicant">
        <nplcit num="10">
          <text>Mohamed Helmi Elnagdi et al., "Studies on 3,5-pyrazolidinediones. IV. Addition of 4-Arylazo-3,5-pyrazolidinediones to Ethyl Acrylate", Bulletin of Them Chemical Society of Japan, vol. 46, pp. 1830-1833, 1973.</text>
        </nplcit>
      </citation>
      <citation srep-phase="applicant">
        <nplcit num="11">
          <text>Günther Ege et al., "A Simple Synthesis of 3(5)-Aminopyrazole", Angew. Chem. internat. Edit, vol. 13, No. 3, pp. 206-207, 1974.</text>
        </nplcit>
      </citation>
      <citation srep-phase="applicant">
        <nplcit num="12">
          <text>Kazumasa Takahashi et al., "Syntheses of 3(5)-Substituted-4-(N-methylanilino)-5(3)-aminopyrazoles by Reaction of beta-Hydroxy-alpha-cyano-enamines with Hydrazines", Journal of Synthetic Organic Chemistry, No. 8, pp. 794-796, 1985.</text>
        </nplcit>
      </citation>
      <citation srep-phase="applicant">
        <nplcit num="13">
          <text>Chiara B. Vincentini et al., "Pyrazolo[3,4-d][1,2,3]Triazole-1-carboxamides and 5-Alkylaminopyrazolo,[3,4-d]oxazoles: Synthesis and Evaluation of the in Vitro Antifungal Activity", I1 Farmaco, Vo. 47, No. 7, 8,pp. 1021-1034, 1992.</text>
        </nplcit>
      </citation>
      <citation srep-phase="applicant">
        <nplcit num="14">
          <text>Edward C. Taylor et al., "The Reaction of Malononitrile with Substituted Hydrazines: New Routes to 4-Aminopyrazolo[3,4-d]pyrimidines", Journal of the merican Chemical Society, vol. 81, No. 10, pp. 2456-2464, 1959.</text>
        </nplcit>
      </citation>
      <citation srep-phase="applicant">
        <nplcit num="15">
          <text>C.B. Vincentini et al., "A New Fused Heterocyclic System: 6H-Pyrazolo[3,4-c][1,2,5]thiadizine 2,2-Dioxide", Journal of Heterocyclic Chemistry, vol. 26, No. 3, pp. 797-803, 1989.</text>
        </nplcit>
      </citation>
      <citation srep-phase="applicant">
        <nplcit num="16">
          <text>E.J. Browne et al., "Triazoles. Part VII. Syntheses of Substituted 1,2,4-Triazoles", Journal of The Chemical Society, pp. 5149-5152, 1962.</text>
        </nplcit>
      </citation>
      <citation srep-phase="applicant">
        <nplcit num="17">
          <text>Philip Magnus et al., "Synthesis of helical Poly-beta-pyrroles. Multiple Atropisomerism Resulting in Helical Enantiomorphic Conformations", Journal of the American Chemical Society, vol. 112, No. 6, pp. 2465-2468, 1990.</text>
        </nplcit>
      </citation>
      <citation srep-phase="applicant">
        <nplcit num="18">
          <text>Paul Carter et al., "Studies on the Synthesis of the Antitumor Agent CC-1065. Synthesis of PDE I and PDE II, Inhibitors of Cyclic Adenosine-3',5'-monophosphate Phosphodiesterase Using the 3,3'-Bipyrrole Strategy", Journal of the American Chemical Society, vol. 109, No. 9, pp. 2711-2717, 1987.</text>
        </nplcit>
      </citation>
      <citation srep-phase="applicant">
        <nplcit num="19">
          <text>H. Koopman, "Investigations on Herbicides IV, The synthesis of 2,6-dichlorobenzonitrile", Recueil, vol. 80, No. 9-10, pp. 1075-1083, 1961.</text>
        </nplcit>
      </citation>
      <citation srep-phase="applicant">
        <nplcit num="20">
          <text>Joseph Bailey, "Synthesis of 1H-Pyrazolo[3,2-c]-s-Triazoles and Derived Azamethine Dyes", Journal of the Chemical Society, pp. 2047-2052, 1977.</text>
        </nplcit>
      </citation>
      <citation srep-phase="applicant">
        <nplcit num="21">
          <text>Mohamed Helmy Elnagdi et al., "Routes for the Synthesis of 3,5-Diaminopyrazoles, 2-Aminopyrazolo[1,5-a]pyrimidines and 5-Aminopyrazolo[1,5-a]pyramidines", Journal f. prakt. chemie, Band 320, heft 4, pp. 533-538, 1978.</text>
        </nplcit>
      </citation>
    </references-cited>
    <parties>
      <applicants>
        <applicant data-format="original" app-type="applicant" sequence="1">
          <addressbook lang="en">
            <orgname>L'Oreal</orgname>
            <address>
              <address-1>Paris, FR</address-1>
              <city>Paris</city>
              <country>FR</country>
            </address>
          </addressbook>
          <nationality>
            <country>FR</country>
          </nationality>
        </applicant>
        <applicant data-format="questel" app-type="applicant" sequence="2">
          <addressbook lang="en">
            <orgname>L'OREAL</orgname>
          </addressbook>
          <nationality>
            <country>FR</country>
          </nationality>
        </applicant>
      </applicants>
      <inventors>
        <inventor data-format="original" sequence="1">
          <addressbook lang="en">
            <name>Vidal, Laurent</name>
            <address>
              <address-1>Paris, FR</address-1>
              <city>Paris</city>
              <country>FR</country>
            </address>
          </addressbook>
          <nationality>
            <country>FR</country>
          </nationality>
        </inventor>
        <inventor data-format="original" sequence="2">
          <addressbook lang="en">
            <name>Malle, G{acute over (e)}rard</name>
            <address>
              <address-1>Villiers sur Morin, FR</address-1>
              <city>Villiers sur Morin</city>
              <country>FR</country>
            </address>
          </addressbook>
          <nationality>
            <country>FR</country>
          </nationality>
        </inventor>
      </inventors>
      <agents>
        <agent sequence="1" rep-type="agent">
          <addressbook lang="en">
            <orgname>Finnegan, Henderson, Farabow, Garrett &amp; Dunner, L.L.P.</orgname>
          </addressbook>
        </agent>
      </agents>
    </parties>
    <examiners>
      <primary-examiner>
        <name>Liott, Caroline D.</name>
      </primary-examiner>
    </examiners>
    <pct-or-regional-filing-data>
      <document-id>
        <country>WO</country>
        <doc-number>FR9700506</doc-number>
        <date>19970321</date>
      </document-id>
      <document-id data-format="questel">
        <doc-number>1997WO-FR00506</doc-number>
      </document-id>
    </pct-or-regional-filing-data>
    <pct-or-regional-publishing-data>
      <document-id>
        <country>WO</country>
        <doc-number>9735550</doc-number>
        <kind>A1</kind>
        <date>19971002</date>
      </document-id>
      <document-id data-format="questel">
        <doc-number>WO9735550</doc-number>
      </document-id>
    </pct-or-regional-publishing-data>
    <lgst-data>
      <lgst-status>LAPSED</lgst-status>
    </lgst-data>
  </bibliographic-data>
  <abstract format="original" lang="en" id="abstr_en">
    <p id="P-EN-00001" num="00001">
      <br/>
      The present invention relates to a composition for dyeing keratin fibres, in particular human hair, containing, in a medium which is suitable for dyeing:as coupler, at least one compound of formulaor one of the addition salts with an acid, withR1 denotes, in particular, hydrogen, alkyl, aryl, a heterocycle, halogen,R2 denotes, in particular, hydrogen, halogen, alkoxy, aryloxy, acyloxy, arylthio, alkylthio,R3 has the same meanings as those for R1,Za and Zb, which are different, denote C=O or CR4, with R4 having the same meanings as R1;and at least one oxidation base.
    </p>
  </abstract>
  <description format="original" lang="en" id="desc_en">
    <p num="1">The invention relates to a composition for the oxidation dyeing of keratin fibres, in particular human hair, containing at least one pyrazolopyrimidinoxo compound as coupler and at least one oxidation base.</p>
    <p num="2">
      It is known to dye keratin fibres, and in particular human hair, with dye compositions containing oxidation dye precursors, in particular ortho- or para-phenylene diamines, ortho- or para-aminophenols, and heterocyclic compounds, which are generally referred to as oxidation bases.
      <br/>
      Oxidation dye precursors, or oxidation bases, are colourless or weakly coloured compounds which, when combined with oxidizing products, can give rise to coloured compounds and dyes by a process of oxidative condensation.
    </p>
    <p num="3">It is also known that the shades obtained with these oxidation bases can be varied by combining them with couplers or colour modifiers, the latter being chosen in particular from aromatic meta-diamines, meta-aminophenols, meta-diphenols and certain heterocyclic compounds such as indole compounds.</p>
    <p num="4">The variety of molecules used as oxidation bases and couplers allows a wide range of colours to be obtained.</p>
    <p num="5">
      The so-called "permanent" coloration obtained by means of these oxidation dyes must moreover satisfy a certain number of requirements.
      <br/>
      Thus, it must have no toxicological drawbacks, it must be able to allow shades to be obtained in the desired intensity and it must show good resistance to external agents (light, bad weather, washing, waving, permanent-waving, perspiration, rubbing).
    </p>
    <p num="6">The dyes must also be able to cover grey hair and, lastly, they must be as unselective as possible, i.e. they must allow only the smallest possible colour differences to be obtained along the length of the same keratin fibre, which may, indeed, be differently sensitized (i.e. damaged) between its tip and its root.</p>
    <p num="7">The Applicant has now discovered that it is possible to obtain novel, powerful, unselective and particularly resistant dyes, which are capable of giving rise to intense colorations in varied shades, by using pyrazolopyrimidinoxo compounds as couplers in the presence of an oxidation base.</p>
    <p num="8">This discovery forms the basis of the present invention.</p>
    <p num="9">The subject of the invention is a composition for dyeing keratin fibres, and in particular human keratin fibres such as the hair, characterized in that it comprises, in a medium which is suitable for dyeing.</p>
    <p num="10">as coupler, at least one pyrazolopyrimidinoxo compound of formula (I), or one of the addition salts thereof with an acid.  (Chemical Structure image '2' not included in text)</p>
    <p num="11">
      in which:
      <br/>
      R1 represents: a hydrogen atom; a linear or branched C1 -C20 alkyl radical optionally substituted with 1 or 2 radicals R chosen from the group consisting of halogen, nitro, cyano, hydroxyl, alkoxy, aryloxy, amino, alkylamino, acylamino, carbomoyl, sulphonamido, sulphamoyl, imido, alkylthio, arylthio, aryl, alkoxycarbonyl, acyl; an aryl radical (such as phenyl or naphthyl) optionally substituted with 1 or 2 radicals R as defined above; a 5- or 6-membered heterocycle having at least one nitrogen, oxygen or sulphur atom (such as pyridyl, quinolyl, pyrrolyl, morpholyl, furyl, tetrahydrofuryl, pyrazolyl, triazolyl, tetrazolyl, thiazolyl, oxazolyl, imidazolyl or thiadiazolyl) optionally substituted with 1 or 2 radicals R as defined above;
      <br/>
      when R1 denotes an alkyl radical, an aryl radical or a 5- or 6-membered heterocycle (defined above),
      <br/>
      it can be linked to the carbon atom of the ring via an oxygen, nitrogen or sulphur atom (in this case, R1 becomes XR1 with X.dbd.O, NH, S);
      <br/>
      R1 can also denote a halogen atom (such as bromine, chlorine or fluorine); an acyl radical; a sulphonyl radical; a sulphinyl radical; a phosphonyl radical; a carbamoyl radical; a sulphamoyl radical; a cyano radical; a siloxy radical; an amino radical; an acylamino radical; an acyloxy radical; a carbamoyloxy radical; a sulphonamide radical; an imide radical; a ureido radical; a sulphamoylamino radical; an alkoxycarbonylamino radical; an aryloxycarbonylamino radical; an alkoxycarbonyl radical; an aryloxycarbonyl radical; a carboxyl radical;
      <br/>
      R2 represents: a hydrogen atom; a halogen atom such as bromine, chlorine or fluorine; an acetylamido group; an alkoxy radical (such as, for example: methoxy, ethoxy, propyloxy, benzyloxy, methoxyethoxy, phenoxyethoxy, 2-cyanoethoxy, phenethyloxy, p-chlorobenzyloxy, methoxyethylcarbamoylmethoxy); an aryloxy radical (such as, for example: phenoxy, 4-methoxylphenoxy, 4-nitrophenoxy, 4-cyanophenoxy, 4-methanesulphonamidophenoxy, 4-methanesulphonylphenoxy, 3-methylphenoxy, 1-naphthyloxy); an acyloxy radical (such as, for example: acetoxy, propanoyloxy, benzoyloxy, 2,4-dichlorobenzoyloxy, ethoxyalkyloxy, pyruvyloyloxy, cinnamoyloxy, myristyloxy); an arylthio radical (such as, for example: phenylthio, 4-carboxyphenyltio, 4-methanesulphonylphenylthio); an alkylthio radical (such as, for example: methylthio, ethylthio, propylthio, butylthio, 2-cyanoethylthio, benzylthio, phenethylthio, 2-(diethylamino)ethylthio, ethoxyethylthio, phenoxyethylthio); a heteroarylthio radical (such as, for example: 5-phenyl-2,3,4,5-tetrazolylthio, 2-benzothiazolylthio): a heteroaryloxy radical (such as, for example: 5-phenyl-2,3,4,5-tetrazolyloxy, 2-benzothiazolyloxy); a thiocyano radical; an N,N-diethylthiocarbonylthio radical; a dodecyloxythiocarbonylthio radical; a benzenesulphonamido radical; an N-ethyltoluenesulphonamido radical; a pentafluorobutanamido radical; a 2,3,4,5,6-pentafluorobenzamido radical; a p-cyanophenylureido radical; an N,N-diethylsulphamoylamino radical; a pyrazolyl radical; an imidazolyl radical; a triazolyl radical; a tetrazolyl radical; a benzimiazolyl radical; a 1-benzyl-5-ethoxy-3-hydantoinyl
      <br/>
      radical; a 1-benzyl-3-hydantoinyl radical; 5,5-dimethyl-2,4-dioxo-3-oxazolidinyl; a 2-oxy-1,2-dihydro-1-pyridyl radical; an alkylamido; an arylamido; a radical NRIII RIV with RIII and RIV, which may be identical or different, representing a C1 -C4 alkyl, a hydroxyalkyl; a carboxyl; or an alkoxycarboxylic radical;
      <br/>
      R3 has the same meanings mentioned as those mentioned for the radical R1 ;
      <br/>
      Za and Zb are different and represent a C.dbd.O group or a carbon atom bearing a radical R4 having the same meanings as those mentioned for the radical R1 ;
      <br/>
      and at least one oxidation base.
    </p>
    <p num="12">The addition salts with an acid for the compounds of the invention can be chosen in particular from hydrochlorides, hydrobromides, tertrates, tosylates, benzenesulphonates, sulphates, lactates and acetates.</p>
    <p num="13">Among the radicals R1 of formula (I) defined above, the preferred radicals are chosen from the group consisting of:</p>
    <p num="14">a hydrogen atom; a linear or branched C1 -C4 alkyl; a phenyl; a phenyl substituted with a halogen atom; a C1 -C4 alkyl, a C1 -C4 alkoxy, a nitro group, an amino group, a trifluoromethyl group or a C1 -C4 alkylamino group; a benzyl radical; a benzyl radical substituted with a halogen atom, a C1 -C4 alkoxy, a nitro group, an amino group, a trifluoromethyl group; a C1 -C4 alkylamino, a heterocycle chosen from thiophene, furan and pyridine; a trifluoromethyl radical; a radical (CH2)p --X--(CH2)4 --OR' where p and q are integers, which may be identical or different, between 1 and 3, R' represents H or methyl and X denotes an oxygen atom or a group NR" with R" denoting hydrogen or methyl; a C1 -C4 hydroxylalkyl; a C1 -C4 aminoalkyl; a C1 -C4 alkylamino; a C1 -C4 dialkylamino; a phenyloxycarbonyl; cyano; an arylamino; an alkoxy radical chosen from methoxy, ethoxy, phenoxy; a halogen chosen from chlorine, bromine, fluorine; a carboxyl group; a (C1 -C4) alkoxycarbonyl.</p>
    <p num="15">Among the radicals R1 of formula (I) defined above, the radicals more particularly preferred as chosen from the group consisting of: hydrogen; an alkyl chosen from methyl, ethyl, isopropyl, tert-butyl; a halogen chosen from fluorine and chlorine; phenyl; toluyl; 4-chlorophenyl; 4-methoxyphenyl; 3-methoxyphenyl; 2-methoxyphenyl; benzyl; a heterocycle chosen from pyridyl, furyl and thienyl; trifluoromethyl; hydroxymethyl; aminomethyl; methoxy or ethoxy; methylamino or ethylamino or dimethylamino; carboxyl; methoxycarbonyl or ethoxycarbonyl; cyano.</p>
    <p num="16">Even more particularly, the preferred radicals R1 are chosen from the group consisting of: hydrogen; methyl; ethyl; phenyl; toluyl; 4-chlorophenyl; 4-methoxyphenyl; benzyl; trifluoromethyl; chloro; a methoxy or ethoxy radical; a carboxyl radical; methylamino or dimethylamino; cyano.</p>
    <p num="17">Among the radicals R2 of formula (I) defined above, the preferred radicals are chosen from the group consisting of:</p>
    <p num="18">a hydrogen atom; a C1 -C4 alkoxy; phenoxy; phenoxy substituted with a halogen atom, a C1 -C4 alkyl, a carboxyl, a trifluoromethyl group; an acyloxy radical; benzyloxy; C1 -C4 alkylthio; phenylthio; phenylthio substituted with a halogen atom, a C1 -C4 alkyl, a carboxyl, a trifluoromethyl group; a C1 -C4 alkylamido; phenylamido; a radical NRIII RIV with RIII and RIV, which may be identical or different, representing a C1 -C4 alkyl, a C1 -C4 hydroxyalkyl; a carboxyl; a C1 -C4 alkoxycarboxylic radical.</p>
    <p num="19">Among the radicals R2 of formula (I) defined above, the radicals more particularly preferred are chosen from the group consisting of:</p>
    <p num="20">hydrogen; chlorine or bromine; methoxy or ethoxy; phenoxy; 4-methylphenoxy; acyloxy; benzyloxy; methylthio or ethylthio; phenylthio; 4-methylphenylthio; 2-tert-butylphenylthio; acetamido; phenylacetamido; dimethylamino; diethylamino; ethylmethylamino; ( BETA -hydroxyethyl)methylamino.</p>
    <p num="21">Even more particularly, the preferred radicals R2 are chosen from the group consisting of: hydrogen; chlorine; ethoxy; phenoxy; benzyloxy; acyloxy; acetamido; dimethylamino.</p>
    <p num="22">Among the radicals R3 and R4 of formula (I) defined above, the preferred radicals are chosen from the group consisting of:</p>
    <p num="23">a hydrogen atom; a linear or branched C1 -C4 alkyl optionally substituted with a hydroxyl or amino; a phenyl; a phenyl substituted with one or two groups chosen from a halogen, a C1 -C4 alkyl, a C1 -C4 alkoxy; a hydroxyl; a carboxyl, a nitro group, a C1 -C4 alkylthio, a methylenedioxy group, an amino group, a trifluoromethyl group or a C1 -C4 alkylamino; a benzyl radical; a benzyl radical substituted with a halogen atom, a methyl or isopropyl, methoxy; a C1 -C4 hydroxyalkyl; a C1 -C4 aminoalkyl; a C1 -C4 alkylaminoalkyl; an amino radical; a C1 -C4 alkylamino radical, a halogen such as chlorine or bromine; a trifluoromethyl.</p>
    <p num="24">Among the radicals R3 and R4, the preferred radicals are chosen from the group consisting of: hydrogen; C1 -C4 alkyl (such as methyl; ethyl; isopropyl); halogen (such as chlorine, bromine); amino; C1 -C4 alkylamino (such as methylamino, ethylamino or dimethylamino); an aryl radical (such as phenyl, toluyl, 2-, 3-or 4-chlorophenyl, 3- or 4-hydroxyphenyl, 3- or 4-aminophenyl, 3- or 4-methoxyphenyl, 4-trifluoromethylphenyl); benzyl; hydroxymethyl or hydroxyethyl; aminomethyl or aminoethyl; trifluoromethyl.</p>
    <p num="25">Even more particularly, the preferred radicals R3 and R4 are chosen from the following radicals:</p>
    <p num="26">hydrogen, methyl, ethyl, isopropyl, trifluoromethyl, chlorine, amino, methylamino, ethylamino, phenyl, 4-chlorophenyl, 4-methoxyphenyl.</p>
    <p num="27">Among the preferred compounds of the invention of formula (I), mention may be made of those chosen from the group consisting of:</p>
    <p num="28">(i) pyrazolo�1,5-a�pyrimidin-7-oxo compounds of formula:  (Chemical Structure image '3' not included in text)</p>
    <p num="29">(ii) pyrazolo�1,5-a�pyrimidin-5-oxo compounds of formula:  (Chemical Structure image '4' not included in text)</p>
    <p num="30">in which the radicals R1, R2, R3 and R4 have the same meanings as those mentioned above.</p>
    <p num="31">As examples of compounds of formula (Ia), mention may be made of those for which:</p>
    <p num="32">R1 denotes hydrogen, methyl, ethyl, chlorine, phenyl, methoxy, trifluoromethyl, carboxyl or cyano;</p>
    <p num="33">R2 denotes hydrogen, chlorine or ethoxy;</p>
    <p num="34">R3 and R4 respectively denote: hydrogen and hydrogen; hydrogen and methyl; methyl and hydrogen; hydrogen and amino; chlorine and methyl; chlorine and amino; carboxyl and methyl; hydrogen and trifluoromethyl, or carboxyl and hydrogen.</p>
    <p num="35">
      As compounds of formula (Ia) above, mention may be made most particularly of:
      <br/>
      2-carboxy-5-methylpyrazolo(1,5-a)pyrimidin-7-one,
      <br/>
      2-ethylthio-5-methylpyrazolo�1,5-a�pyrimidin-7-one,
      <br/>
      2-methyl-5-trifluoromethylpyrazolo�1,5-a�pyrimidin-7-one,
      <br/>
      2-phenyl-5-trifluoromethylpyrazolo�1,5-a�pyrimidin-7-one,
      <br/>
      2-carboxy-5-trifluoromethylpyrazolo�1,5-a�pyrimidin-7-one,
      <br/>
      2-ethylthio-5-trifluoromethylpyrazolo�1,5-a�-pyrimidin-7-one,
      <br/>
      5-trifluoromethylpyrazolo�1,5-a�-pyrimidin-7-one,
      <br/>
      5-methylpyrazolo�1,5-a�pyrimidin-7-one,
      <br/>
      6-carboxypyrazolo�1,5-a�pyrimidin-7-one,
      <br/>
      6-carboxy-2-methylpyrazolo�1,5-a�pyrimidin-7-one,
      <br/>
      6-carboxy-2-phenylpyrazolo�1,5-a�pyrimidin-7-one,
      <br/>
      6-carboxy-2-ethylthiopyrazolo�1,5-a�pyrimidin-7-one,
      <br/>
      2,6-dicarboxypyrazolo�1,5-a�pyrimidin-7-one,
      <br/>
      2-methyl-6-ethoxycarbonylpyrazolo�1,5-a�pyrimidin-7-one,
      <br/>
      2-(2'-furyl)-6-methylpyrazolo�1,5-a�pyrimidin-7-one,
      <br/>
      2-(2'-thienyl)-6-methylpyrazolo�1,5-a�pyrimidin-7-one,
      <br/>
      3-ethoxycarbonyl-6-methylpyrazolo�1,5-a�pyrimidin-7-one,
      <br/>
      2-methyl-5-methoxymethylpyrazolo�1,5-a�pyrimidin-7-one,
      <br/>
      2-tert-butyl-5-trifluoromethylpyrazolo�1,5-a�pyrimidin-7-one, and the addition salts thereof with an acid.
    </p>
    <p num="36">As examples of compounds of formula (Ib), mention may be made of those for which R1, R2, R3 and R4 have the same meanings as those mentioned in the examples of compounds of formula (Ia) defined above.</p>
    <p num="37">
      As compounds of formula (Ib) above, mention may be made most particularly of:
      <br/>
      pyrazol�1,5-a�pyrimidin-5-one,
      <br/>
      2-methylpyrazolo�1,5-a�pyrimidin-5-one,
      <br/>
      2,7-dimethylpyrazolo�1,5-a�pyrimidin-5-one,
      <br/>
      2-phenylpyrazolo�1,5-a�pyrimidin-5-one,
      <br/>
      2-ethylthiopyrazolo�1,5-a�pyrimidin-5-one,
      <br/>
      2-carboxypyrazolo�1,5-a�pyrimidin-5-one,
      <br/>
      7-aminopyrazolo�1,5-a�pyrimidin-5-one,
      <br/>
      7-amino-2-methylpyrazolo�1,5-a�pyrimidin-5-one,
      <br/>
      7-amino-2-phenylpyrazole�1,5-a�pyrimidin-5-one,
      <br/>
      7-amino-2-ethylthiopyrazolo�1,5-a�pyrimidin-5-one,
      <br/>
      7-amino-2-carboxypyrazolo�1,5-a�pyrimidin-5-one,
    </p>
    <p num="38">and the addition salts thereof with an acid.</p>
    <p num="39">The compounds of the present invention and their processes are described in patent application EP-A-304,001.</p>
    <p num="40">
      Their synthetic intermediates are described in patent applications EP-A-591,103, WO 92/04349 and EP-A-320,764 and in the following publications:
      <br/>
      C.
      <br/>
      Musante, Gazetta Chim.
      <br/>
      Ital. 73, 355, 1943;
      <br/>
      H.
      <br/>
      Dorn, Liebigs Ann.
      <br/>
      Chem. 707, 141, 1967;
      <br/>
      H.
      <br/>
      Dorn, Liebigs Ann.
      <br/>
      Chem. 717, 118, 1968;
      <br/>
      P.
      <br/>
      Arnold, Angew.
      <br/>
      Chem. Int. Ed., 13, 205, 1974;
      <br/>
      K.
      <br/>
      Takahashi, Synthesis, 794, 1985;
      <br/>
      C. B. Vicentini, Il Farmaco, 47, (7, 8), 1021, 1992;
      <br/>
      K. S. Hartke, J. Am. Chem. Soc., 81, 2456, 1959;
      <br/>
      C. B. Vicentini, J. Het. Chem., 26, 797, 1989.
    </p>
    <p num="41">The compound(s) of formula (I) preferably represent(s) from 0.0005 to 12% by weight approximately relative to the total weight of the dye composition, and even more preferably from 0.005 to 6% by weight approximately relative to this weight.</p>
    <p num="42">
      The nature of the oxidation base(s) which can be used in the dye composition according to the invention is not critical.
      <br/>
      This or these oxidation bases is(are) preferably chosen from para-phenylenediamines, bis(phenyl)alkylenediamines, para-aminophenols, ortho-aminophenols and heterocyclic bases, and the addition salts thereof with an acid.
    </p>
    <p num="43">Among the para-phenylenediamines which can be used as oxidation bases in the dye composition according to the invention, mention may be made in particular of the compounds corresponding to formula (II) below:  (Chemical Structure image '5' not included in text)</p>
    <p num="44">R5 represents a hydrogen atom, a C1 -C4 alkyl, C1 -C4 monohydroxyalkyl, C2 -C4 polyhydroxyalkyl or (C1 -C4)alkoxy(C1 -C4)alkyl radical,</p>
    <p num="45">R6 represents a hydrogen atom of a C1 -C4 alkyl, C1 -C4 monohydroxyalkyl or C2 -C4 polyhydroxyalkyl radical,</p>
    <p num="46">R7 represents a hydrogen atom, a halogen atom such as a chlorine atom, or a C1 -C4 alkyl, sulpho, carboxyl, C1 -C4 monohydroxyalkyl or C1 -C4 hydroxyalkoxy radical,</p>
    <p num="47">R8 represents a hydrogen atom or a C1 -C4 alkyl radical.</p>
    <p num="48">In formula (II) above, and when R7 is other than a hydrogen atom, then R5 and R6 preferably represent a hydrogen atom and R7 is preferably identical to R8, and when R7 represents a halogen atom, then R5, R6 and R8 preferably represent a hydrogen atom.</p>
    <p num="49">Among the para-phenylenediamines of formula (II) above, mention may be made more particularly of para-phenylenediamine, para-toluylenediamine, 2-isopropyl-para-phenylenediamine, 2- BETA -hydroxyethyloxy-para-phenylenediamine 2,6-diethyl-para-phenylenediamine, 4-amino-1-( BETA -methoxyethyl)aminobenzene and 2-chloro-para-phenylenediamine, and the addition salts thereof with an acid.</p>
    <p num="50">Among the bis(phenyl)alkylenediamines which can be used as oxidation bases in the dye composition according to the invention, mention may be made in particular of the compounds corresponding to formula (III) below, and the addition salts thereof with an acid:  (Chemical Structure image '6' not included in text)</p>
    <p num="51">
      in which:
      <br/>
      Q1 and Q2, which may be identical or different, represent a hydroxyl radical or a radical NHR12 in which
      <br/>
      R12 represents a hydrogen atom of a C1 -C4 alkyl radical,
      <br/>
      R9 represents a hydrogen atom or a C1 -C4 alkyl, C1 -C4 monohydroxyalkyl, C2 -C4 polyhydroxyalkyl or C1 -C4 aminoalkyl radical in which the amino residue may be substituted,
      <br/>
      R10 and R11, which may be identical or different represent a hydrogen or halogen atom or a C1 -C4 alkyl radical,
      <br/>
      W represents a radical taken from the group consisting of the following radicals  (Chemical Structure image '7' not included in text)
    </p>
    <p num="52">in which n is an integer between 0 and 8 inclusive and m is an integer between 0 and 4 inclusive.</p>
    <p num="53">Among the bis(phenyl)alkylenediamines of formula (III) above, mention may be made more particularly of N,N'-bis( BETA -hydroxyethyl)-N,N'-bis-(4'-aminophenyl) -1,3-diamino-2-propanol, N,N'-bis( BETA -hydroxyethyl)-N,N'-bis(4'-aminophenyl)ethylenediamine, N,N'-bis( BETA -hydroxyethyl)-N,N'-bis(4-aminophenyl) tetramethylenediamine, and N,N'-bis(ethyl)-N,N'-bis (4'-amino-3'-methylphenyl) ethylenediamine, and the addition salts thereof with an acid.</p>
    <p num="54">Among these bis(phenyl)alkylenediamines of formula (III), N,N'-bis( BETA -hydroxyethyl)-N,N'-bis(4'-aminophenyl) -1,3-diaminopropanol or one of the addition salts thereof with an acid are particularly preferred.</p>
    <p num="55">Among the para-aminophenols which can be used as oxidation bases in the dye composition according to the invention, mention may be made in particular of the compounds corresponding to formula (IV) below, and the addition salts thereof with an acid.  (Chemical Structure image '8' not included in text)</p>
    <p num="56">
      in which:
      <br/>
      R13 represents a hydrogen atom or a C1 -C4 alkyl, C1 -C4 monohydroxyalkyl, (C1 -C4)alkoxy(C1 -C4)alkyl or C1 -C4 aminoalkyl radical, R14 represents a hydrogen or fluorine atom or a C1 -C4 alkyl, C1 -C4 monohydroxyalkyl, C2 -C4 polyhydroxyalkyl, C1 -C4 aminoalkyl, cyano(C1 -C4)alkyl or (C1 -C4)alkoxy(C1 -C4)alkyl radical, it being understood that at least one of the radicals R13 or R14 represents a hydrogen atom.
    </p>
    <p num="57">Among the para-aminophenols of formula (IV) above, mention may be made more particularly of para-aminophenyl, 4-amino-3-methylphenol, 4-amino-3-fluorophenol, 4-amino-4-hydroxymethylphenol, 4-amino-2-methylphenol, 4-amino-2-hydroxymethylphenol, 4-amino-2-methoxymethylphenol, 4-amino-2-aminomethylphenol and 4-amino-2-( BETA -hydroxyethylaminomethyl)phenol, and the addition salts thereof with an acid.</p>
    <p num="58">Among the ortho-aminophenols which can be used as oxidation bases in the dye composition according to the invention, mention may be made in particular of 2-aminophenol, 2-amino-1-hydroxy-5-methylbenzene, 2-amino-1-hydroxy-6-methylbenzene and 5-acetamido-2-aminophenol, and the addition salts thereof with an acid.</p>
    <p num="59">Among the heterocyclic bases which can be used as oxidation bases in the dye composition according to the invention, mention may be made in particular of pyridine derivatives, pyrimidine derivatives and pyrazole derivatives, and the addition salts thereof with an acid.</p>
    <p num="60">Among the pyridine derivatives, mention may be made more particularly of the compounds described, for example, in GB patents 1,026,978 and 1,153,196, such as 2,5-diaminopyridine, and the addition salts thereof with an acid.</p>
    <p num="61">Among the pyrimidine derivatives, mention may be made more particularly of compounds described, for example, in German patent DE 2,359,399 or Japanese patents JP 88-169,571 and JP 91-333,495, such as 2,4,5,6-tetraaminopyrimidine and 4-hydroxy-2,5,6-triaminopyrimidine, and the addition salts thereof with an acid.</p>
    <p num="62">Among the pyrazole derivatives, mention may be made more particularly of the compounds described in patents DE 3,843,892 and DE 4,133,957 and patent applications WO 94/08969 and WO 94/08970, such as 4,5-diamino-1-methylpyrazole, 3,4-diaminopyrazole and 1-(4'-chlorobenzyl)-4,5-diaminopyrazole and the addition salts thereof with an acid.</p>
    <p num="63">According to the invention, the oxidation base(s) preferably represent(s) from 0.0005 to 12% by weight approximately relative to the total weight of the dye composition, and even more preferably from 0.005 to 6% by weight approximately relative to this weight.</p>
    <p num="64">The dye composition according to the invention can also contain one or more additional couplers other than the compounds of formula (I) and/or one or more direct dyes, so as to vary the shades obtained with the oxidation bases or to enrich the shades with glints.</p>
    <p num="65">The additional couplers which can be used in the composition according to the invention can be chosen from the couplers used conventionally in oxidation dyeing, and among which mention may be made in particular of meta-phenylenediamines, meta-aminophenols, meta-diphenols and heterocyclic couplers such as, for example, indole derivatives and indoline derivatives, and the addition salts thereof with an acid.</p>
    <p num="66">These couplers can be chosen in particular from 2-methyl-5-aminophenol, 5-N-( BETA -hydroxyethyl)amino-2-methylphenol, 3-aminophenol, 1,3-dihydroxybenzene, 1,3-dihydroxy-2-methylbenzene, 4-chloro-1,3-dihydroxybenzene, 2,4-diamino-1-( BETA -hydroxyethyloxy)benzene, 2-amino-4-( BETA -hydroxyethylamino)-1-methoxybenzene, 1,3-diaminobenzene, 1,3-bis(2,4-diaminophenoxy)propane, sesamol,  ALPHA -naphthol, 6-hydroxyindole, 4-hydroxyindole, 4-hydroxy-N-methylindole and 6-hydroxyindoline, and the addition salts thereof with an acid.</p>
    <p num="67">When they are present, these additional couplers preferably represent from 0.0005 to 5% by weight approximately relative to the total weight of the dye composition, and even more preferably from 0.005 to 3% by weight approximately relative to this weight.</p>
    <p num="68">The addition salts with an acid for the oxidation base(s) and/or for the additional couplers which can be used in the dye composition of the invention are chosen in particular from the hydrochlorides, hydrobromides, sulphates, tartrates, lactates and acetates.</p>
    <p num="69">
      The medium which is suitable for dyeing for the support) generally consists of water or of a mixture of water and at least on organic solvent for dissolving the compounds which would not be sufficiently water-soluble.
      <br/>
      As organic solvents, mention may be made, for example, of C1 -C4 lower alcohols, such as ethanol and isopropanol; glycerol; glycols and glycol ethers such as 2-butoxyethanol, propylene glycol, propylene glycol monomethyl ether, diethylene glycol monoethyl ether and monomethyl ether, and aromatic alcohols such as benzyl alcohol or phenoxyethanol, similar products and mixtures thereof.
    </p>
    <p num="70">The solvents can be present in proportions preferably of between 1 and 40% by weight approximately relative to the total weight of the dye composition, and even more preferably between 5 and 30% by weight approximately.</p>
    <p num="71">
      The pH of the dye composition in accordance with the invention is generally between 3 and 12.
      <br/>
      It can be adjusted to the desired value using acidifying or basifying agents usually used to dye keratin fibres.
    </p>
    <p num="72">Among the acidifying agents, mention may be made, by way of example, of inorganic or organic acids such as hydrochloric acid, orthophosphoric acid, carboxylic acids such as tartaric acid, citric acid and lactic acid, and sulphonic acids.</p>
    <p num="73">Among the basifying agents, mention may be made, by way of example, of aqueous ammonia, alkaline carbonates, alkanolamines such as mono-, di- and triethanolamines and derivatives thereof, sodium hydroxide, potassium hydroxide and the compounds of formula (IV) below:  (Chemical Structure image '9' not included in text)</p>
    <p num="74">in which R is a propylene residue optionally substituted with a hydroxyl group or a C1 -C4 alkyl radical, R15, R16, R17 and R18, which may be identical or different, represent a hydrogen atom or a C1 -C4 alkyl or C1 -C4 hydroxyalkyl radical.</p>
    <p num="75">The dye composition according to the invention can also contain various adjuvants conventionally used in compositions for dyeing the hair, such as anionic, cationic, nonionic, amphoteric or zwitterionic surfactants or mixtures thereof, anionic, cationic, nonionic, amphoteric or zwitterionic polymers or mixtures thereof, inorganic or organic thickeners, antioxidants, penetration agents, sequestering agents, fragrances, buffers, dispersing agents conditioners such as, for example, silicones, film-forming agents, preserving agents and opacifiers.</p>
    <p num="76">Needless to say, the person skilled in the art will take care to select the optional complementary compound(s) mentioned above, such that the advantageous properties intrinsically associated with the dye composition according to the invention are not, or not substantially, adversely affected by the addition(s) envisaged.</p>
    <p num="77">The dye composition according to the invention can be in various forms, such as in the form of liquids, creams or gels or in any other form which is suitable for dyeing keratin fibres, and the particular human hair.</p>
    <p num="78">The subject of the invention is also the use of the pyrazolopyrimidinoxos of formula (I) above, as couplers, in combination with at least one oxidation base base for the oxidation dyeing of keratin fibres, in particular human keratin fibres such as the hair.</p>
    <p num="79">Another subject of the invention is a process for the oxidation dyeing of keratin fibres, and in particular human keratin fibres such as the hair, using the dye composition as defined above.</p>
    <p num="80">According to this process, at least one dye composition as defined above is applied to the fibres, the colour being developed at acidic, neutral or alkaline pH using an oxidizing agent which is added to the dye composition only at the moment of use, or which is present in an oxidizing composition that is applied simultaneously or sequentially in a separate manner.</p>
    <p num="81">
      According to a particularly preferred embodiment of the dyeing process according to the invention, the dye composition described above is mixed, at the moment of use, with an oxidizing composition containing, in a medium which is suitable for dyeing, at least one oxidizing agent that is present in an amount which is sufficient to develop a coloration.
      <br/>
      The mixture obtained is then applied to the keratin fibres and is left to stand on them for 3 to 50 minutes approximately, preferably 5 to 10 minutes approximately, after which the fibres are rinsed, washed with shampoo, rinsed again and dried.
    </p>
    <p num="82">
      The oxidizing agent present in the oxidizing composition as defined above can be chosen from the oxidizing agents conventionally used for the oxidation dyeing of keratin fibres, and among which mention may be made of hydrogen peroxide, urea peroxide, alkali metal bromates and persalts such as perborates and persulphates.
      <br/>
      Hydrogen peroxide is particularly preferred.
    </p>
    <p num="83">
      The pH of the oxidizing composition containing the oxidizing agent as defined above is such that after mixing with the dye composition, the pH of the resulting composition applied to the keratin fibres preferably ranges between 3 and 12 approximately and even more preferably between 5 and 11.
      <br/>
      It is adjusted to the desired value using acidifying or basifying agent usually used to dye keratin fibres and as defined above.
    </p>
    <p num="84">The oxidizing composition as defined above can also contain various adjuvants conventionally used in compositions for dyeing the hair and as defined above.</p>
    <p num="85">The composition which is finally applied to the keratin fibres can be in various forms, such as in the form of liquids, creams or gels or in any other form which is suitable for dyeing keratin fibres, and in particular human hair.</p>
    <p num="86">Another subject of the invention is a dyeing "kit" or multi-compartment device or any other multi-compartment packaging system, in which a first compartment contains the dye composition as defined above and a second compartment contains an oxidizing composition as defined above.</p>
    <p num="87">These devices can be equipped with means which allow the desired mixture to be delivered onto the hair, such as the devices described in patent FR-2,586,913 in the name of the Applicant.</p>
    <heading>EXAMPLES</heading>
    <p num="88">Examples 1 to 3 of Dyeing in Alkaline Medium</p>
    <p num="89">
      --
      <br/>
      --      Examples                1           2      3
      <br/>
      --      2,7-Dimethylpyrazolo�1,5-a�- 0.490       0.490  --
      <br/>
      --      pyrimidin-5-one (coupler)
      <br/>
      --      2,5-Dimethylpyrazolo�1,5-a�- --     -- 0.490
      <br/>
      --      pyrimidin-7-one (coupler)
      <br/>
      --      Para-phenylenediamine   0.324       0.324  0.324
      <br/>
      --      (oxidation base)
      <br/>
      --      Common dye support      No. 1       No. 1  No. 1
      <br/>
      --      Demineralized water qs  100 g       100 g  100 g
    </p>
    <p num="90">NB: The 2,7 -dimethylpyrazolo�1,5-a�pyrimidin-5-one was prepared according to the process described in patent application EP-A-304,001, and the 2,5-dimethylpyrazolo�1,5-a�pyrimidin-7-one is sold under the trade name KM 00085 by the company Maybridge</p>
    <p num="91">Common dye support No. 1:</p>
    <p num="92">
      --
      <br/>
      --        Benzyl alcohol                         2.0 g
      <br/>
      --        Polyethylene glycol containing 6 mol   3.0 g
      <br/>
      --        of ethylene oxide
      <br/>
      --        Ethanol                                20.0 g
      <br/>
      --        (C8 -C10) Alkylpolyglucoside as an  6.0 g
      <br/>
      --        aqueous solution containing 60% active
      <br/>
      --        material, buffered with ammonium
      <br/>
      --        citrate, sold under the name Oramix
      <br/>
      --        CG110 by the company Seppic
      <br/>
      --        Aqueous ammonia containing 20% NH3   10.0 g
      <br/>
      --        Sodium metabisulphite                 0.228 g
      <br/>
      --        Sequestering agent                    qs
    </p>
    <p num="93">At the moment of use, the dye composition of Example 1 above was mixed with an equal weight of 20-volumes hydrogen peroxide solution (6% by weight); each of the dye compositions of Examples 2 and 3 above was mixed with an equal weight of an aqueous ammonium persulphate solution at a concentration of 6 * 10-3 mol %.</p>
    <p num="94">
      Each mixture obtained was applied for 30 minutes to locks of permanent-waved or non-permanent-waved natural grey hair containing 90% white hairs, at a rate of 10 g per 1 g of hair.
      <br/>
      After rinsing, washing with a standard shampoo and drying, the locks were dyed in the shades features in Table 1 below:
    </p>
    <p num="95">
      -- TABLE 1
      <br/>
      --                                          Shade obtained on
      <br/>
      --                         Shade obtained   permanent-waved
      <br/>
      --                         on natural grey  grey hair
      <br/>
      --           pH of the     hair containing  containing 90%
      <br/>
      -- Example   mixture       90% white hairs  white hairs
      <br/>
      -- 1         9.9           Iridescent       Slightly red
      <br/>
      --                                          iridescent
      <br/>
      -- 2         10.1          Iridescent       Iridescent bright
      <br/>
      --                                          red
      <br/>
      -- 3         9.8           Slightly golden  Slightly golden
      <br/>
      --                         very light       very light blond
      <br/>
      --                         blond
    </p>
    <p num="96">Example 4 of Dying in Neutral Medium</p>
    <p num="97">The following dye composition, in accordance with the invention, was prepared:</p>
    <p num="98">
      --
      <br/>
      --        2,5-Dimethylpyrazolo�1,5-a�- 0.490 g
      <br/>
      --        pyrimidin-7-one
      <br/>
      --        Para-phenylenediamine                 0.324 g
      <br/>
      --        Benzyl alcohol                         2.0 g
      <br/>
      --        Polyethylene glycol 6 EO               3.0 g
      <br/>
      --        Ethanol                                20.0 g
      <br/>
      --        (C8 -C10) Alkylpolyglucoside as an aqueous  6.0 g
      <br/>
      --        solution containing 60% active material
      <br/>
      --        buffered with ammonium citrate, sold
      <br/>
      --        under the name Oramix CG110 by the
      <br/>
      --        company Seppic
      <br/>
      --        K2 HPO4 /KH2 PO4 (1.5M/1M) buffer  10.0 g
      <br/>
      --        Sodium metabisulphite                 0.228 g
      <br/>
      --        Sequestering agent                    qs
    </p>
    <p num="99">At the moment of use, the dye composition of Example 4 above was mixed with an equal weight of an aqueous ammonium persulphate solution at a concentration of 6 * 10-3 mol %.</p>
    <p num="100">
      The mixture obtained had a pH of 7.2, and was applied for 30 minutes to locks of natural grey hair containing 90% white hairs, at a rate of 10 g per 1 g of hair.
      <br/>
      After rinsing, washing with a standard shampoo and drying, the locks were dyed in a slightly golden very light blond shade.
    </p>
    <p num="101">Examples 5 to 7 of Dyeing in Alkaline Medium</p>
    <p num="102">
      --
      <br/>
      --      Examples                  5           6      7
      <br/>
      --      2-Methyl-5-methoxymethyl- 0.579       -- --
      <br/>
      --      pyrazolo�1,5-a�pyrimidin-7-one
      <br/>
      --      (coupler)
      <br/>
      --      2-tert-Butyl-5-           --     0.777  --
      <br/>
      --      trifluoromethylpyrazolo-
      <br/>
      --      �1,5-a�pyrimidin-7-one
      <br/>
      --      (coupler)
      <br/>
      --      2-Methyl-6-ethyoxycarbonyl- --     -- 0.663
      <br/>
      --      pyrazolo�1,5-a�pyrimidin-7-one
      <br/>
      --      (coupler)
      <br/>
      --      1,3-Dimethyl-4,5-diamino- 0.597       -- 0.597
      <br/>
      --      pyrazole dihydrochloride
      <br/>
      --      (oxidation base)
      <br/>
      --      N,N-Bis( BETA -hydroxyethyl)-para- --     0.807  --
      <br/>
      --      phenylenediamine dihydro-
      <br/>
      --      chloride (oxidation base)
      <br/>
      --      Common dye support        No. 1       No. 1  No. 1
      <br/>
      --      Demineralized water qs    100 g       100 g  100 g
    </p>
    <p num="103">NB: The 2-methyl-5-methoxymethylpyrazolo�1,5-a�pyrimidin-7-one and 2-methyl-6-ethoxycarbonylpyrazolo�1,5-a�pyrimidin-7-one are sold, respectively under the trade names KN 00739 and KM 00318 by the company Maybridge.</p>
    <p num="104">Common dye support No. 1:</p>
    <p num="105">This is identical to the one used for Examples 1 to 3 above.</p>
    <p num="106">At the moment of use, the dye compositions of Examples 5 and 6 above were mixed with an equal weight of 20-volumes hydrogen peroxide solution (6% by weight); the dye composition of Example 7 above was mixed with an equal weight of an aqueous ammonium persulphate solution at a concentration of 6 * 10-3 mol %.</p>
    <p num="107">
      Each mixture obtained was applied for 30 minutes to locks of permanent-waved or non-permanent-wave natural grey hair containing 90% white hairs, at a rate of 10 g per 1 g of hair.
      <br/>
      After rinsing, washing with a standard shampoo and drying, the locks were dyed in the shades featured in Table 2 below:
    </p>
    <p num="108">
      -- TABLE 2
      <br/>
      --                                          Shade obtained on
      <br/>
      --                           Shade obtained permanent-waved
      <br/>
      --                           on natural grey grey hair
      <br/>
      --             pH of the     hair containing containing 90%
      <br/>
      -- Example     mixture       90% white hairs white hairs
      <br/>
      -- 5           9.9           Very light     Light rosewood
      <br/>
      --                           rosewood
      <br/>
      -- 6           9.9           Bottle green   Bottle green
      <br/>
      -- 7           9.8           Light golden   Light golden
      <br/>
      --                           blond          blond
    </p>
  </description>
  <claims format="original" lang="en" id="claim_en">
    <claim num="1">
      <claim-text>What is claimed is:</claim-text>
      <claim-text>1.</claim-text>
      <claim-text>A process for the oxidation dyeing of keratin fibers comprising</claim-text>
      <claim-text>(a) applying to the keratin fibers an effective amount for dyeing of at least one dyeing composition; (b) developing color at acidic, neutral, or alkaline pH in the presence of an oxidizing agent which is added to said at least one dyeing composition at the same time said at least one dyeing composition is applied, or which is present in an oxidizing composition that is applied:</claim-text>
      <claim-text>- (i) separately from said at least one dyeing composition at the same time that said at least one dyeing composition is applied to the fibers, or - (ii) sequentially with said at least one dyeing composition, wherein said at least one dyeing composition comprises, in a medium which is suitable for dyeing, at least one oxidation base and at least one coupler chosen from pyrazolopyrimidinoxo compounds of formula (I) and acid addition salts thereof:  (Chemical Structure image '10' not included in text)</claim-text>
      <claim-text>in which: R1 and R2 are each independently chosen from a hydrogen atom;</claim-text>
      <claim-text>a linear or branched C1 -C20 alkyl radical, unsubstituted or substituted with 1 or 2 radicals R;</claim-text>
      <claim-text>an aryl radical, unsubstituted or substituted with 1 or 2 radicals R;</claim-text>
      <claim-text>and a 5- or 6-membered heterocycle having at least one nitrogen, oxygen or sulphur atom, unsubstituted or substituted with 1 or 2 radicals R; wherein R is chosen from halogen, nitro, cyano, hydroxyl, C1 -C4 alkyl, haloalkyl, carboxyl, alkoxy, aryloxy, amino, alkylamino, acylamino, carbamoyl, sulphonamido, sulphamoyl, imido, alkylthio, arylthio, aryl, alkoxycarbonyl, and acyl groups; with the proviso that when R1 is a linear or branched C1 -C20 alkyl radical, an aryl radical or a 5- or 6-membered heterocycle, R1 may be linked to the carbon atom of the ring via an oxygen, nitrogen or sulphur atom, such that R1 is XR1 wherein X is O, NH, or S; R1 and R3 can each also independently be chosen from a halogen atom;</claim-text>
      <claim-text>an acyl radical;</claim-text>
      <claim-text>a sulphonyl radical;</claim-text>
      <claim-text>a sulphinyl radical;</claim-text>
      <claim-text>a phosphonyl radical;</claim-text>
      <claim-text>a haloalkyl radical;</claim-text>
      <claim-text>a carbamoyl radical;</claim-text>
      <claim-text>a sulphamoyl radical;</claim-text>
      <claim-text>a cyano radical;</claim-text>
      <claim-text>a siloxy radical;</claim-text>
      <claim-text>an amino radical;</claim-text>
      <claim-text>an acylamino radical;</claim-text>
      <claim-text>an acyloxy radical;</claim-text>
      <claim-text>an alkoxy radical;</claim-text>
      <claim-text>an aryloxy radical;</claim-text>
      <claim-text>an alkylthio radical;</claim-text>
      <claim-text>a carbamoyloxy radical;</claim-text>
      <claim-text>a sulphonamide radical;</claim-text>
      <claim-text>an imide radical;</claim-text>
      <claim-text>a ureido radical;</claim-text>
      <claim-text>a sulphamoylamino radical;</claim-text>
      <claim-text>an alkoxycarbonylamino radical;</claim-text>
      <claim-text>an aryloxycarbonylamino radical;</claim-text>
      <claim-text>an alkoxycarbonyl radical;</claim-text>
      <claim-text>an aryloxycarbonyl radical;</claim-text>
      <claim-text>and a carboxyl radical; R2 is chosen from a hydrogen atom;</claim-text>
      <claim-text>a halogen atom;</claim-text>
      <claim-text>an acetylamido group;</claim-text>
      <claim-text>an alkoxy radical;</claim-text>
      <claim-text>an aryloxy radical;</claim-text>
      <claim-text>an acyloxy radical;</claim-text>
      <claim-text>an arylthio radical;</claim-text>
      <claim-text>an alkylthio radical;</claim-text>
      <claim-text>a heteroarylthio radical;</claim-text>
      <claim-text>a heteroaryloxy radical;</claim-text>
      <claim-text>a thiocyano radical;</claim-text>
      <claim-text>an N,N-diethylthiocarbonylthio radical;</claim-text>
      <claim-text>a dodecyloxythiocarbonylthio radical;</claim-text>
      <claim-text>a benzenesulphonamido radical;</claim-text>
      <claim-text>an N-ethyltoluenesulphonamido radical;</claim-text>
      <claim-text>a pentafluorobutanamide radical;</claim-text>
      <claim-text>a 2,3,4,5,6-pentafluorobenzamido radical;</claim-text>
      <claim-text>a p-cyanophenylureido radical;</claim-text>
      <claim-text>an N,N-diethylsulphamoylamino radical;</claim-text>
      <claim-text>a pyrazolyl radical;</claim-text>
      <claim-text>an imidazolyl radical;</claim-text>
      <claim-text>a triazolyl radical;</claim-text>
      <claim-text>a tetrazolyl radical, a benzimidazolyl radical;</claim-text>
      <claim-text>a 1-benzyl-5-ethoxy-3-hydantoinyl radical;</claim-text>
      <claim-text>a 1-benzyl-3-hydantoinyl radical;</claim-text>
      <claim-text>5,5-dimethyl-2,4-dioxo-3-oxazolidinyl a 2-oxy-1,2-dihydro-1-pyridyl radical;</claim-text>
      <claim-text>an alkylamido;</claim-text>
      <claim-text>an arylamido;</claim-text>
      <claim-text>and a radical NRIII RIV wherein RIII and RIV are independently chosen from a C1 -C4 alkyl, a hydroxyalkyl, a carboxyl, or an alkoxycarboxylic radical;</claim-text>
      <claim-text>wherein all of said radicals may be substituted or unsubstituted, and Za and Zb are different from each other and represent a C.dbd.O group or CR4 wherein R4 independently has the same definition as given above for R1.</claim-text>
    </claim>
    <claim num="2">
      <claim-text>2. A process according to claim 1, wherein said keratin fibers are human hair.</claim-text>
    </claim>
    <claim num="3">
      <claim-text>3. A process according to claim 1, wherein the oxidizing agent is hydrogen peroxide, urea peroxide, an alkali metal bromate, or persalt.</claim-text>
    </claim>
    <claim num="4">
      <claim-text>4. A process according to claim 3, wherein the oxidizing agent is a persalt, and further wherein said persalt is a perborate or persulphate.</claim-text>
    </claim>
    <claim num="5">
      <claim-text>5. A process according to claim 1, wherein the oxidizing agent is hydrogen peroxide.</claim-text>
    </claim>
    <claim num="6">
      <claim-text>6. A process according to claim 1, wherein before said applying step, said at least one dyeing composition is mixed with an oxidizing composition comprising, in a medium suitable for dyeing, at lest one oxidizing agent in an amount sufficient to develop coloration; after said developing step, said mixture is left on said keratin fibers for a time ranging from about 3 to about 50 minutes;</claim-text>
      <claim-text>and said keratin fibers are rinsed, washed, rinsed again and dried.</claim-text>
    </claim>
    <claim num="7">
      <claim-text>7. A process according to claim 6, wherein said time ranges from about 5 to about 30 minutes.</claim-text>
    </claim>
  </claims>
</questel-patent-document>